Gabriel NicolasContreras Martin United StatesUniversity of Miami Miller School of Medicine

I, Gabriel Contreras, MD, MPH, earned my medical degree in 1984 from the Autonomous University of Guadalajara in Mexico. I trained in Internal medicine, nephrology, hypertension, critical care, and earned a degree as Master in Public Health between 1989 and 2003. In 1996, I joined the School of Medicine at the University of Miami. During my time as faculty in the Department of Medicine, I have been involved in the development and establishment of a successful clinical research program in the Division of Nephrology. I have an ongoing commitment to improving kidney disease outcomes among racial and ethnic minorities throughout the clinical research program at the University of Miami, Miller School of Medicine.

Institution

Day 1 - Sunday April 14, 2024

Time	Session

09:00 10:30	Precise Phenotyping and Treatment SK01 HeatherReich Chairperson heather.reich@uhn.caCanadaUniversity of Toronto, University Health Network SebastiánJaurretche Chairperson sebastianjaurretche@hotmail.comArgentinaSanatorio Parque SA Deciphering the IGAN Cell Atlas JulioSaez-Rodriguez Speaker julio.saez@uni-heidelberg.deGermanyHeidelberg University Complement-mediated Kidney Diseases in the Era of Complement Inhibitors MarinaVivarelli Speaker marina.vivarelli@opbg.netItalyLaboratory of Nephrology, Bambino Gesù Children's Hospital CART-T JonathanHogan Speaker jonathan.hogan@cabalettabio.comCabaletta Bio New Targets to Reduce the Burden of Rare Kidney Diseases LauraMariani Speaker lmariani@umich.eduUnited StatesUniversity of Michigan Q and A Hall C4
11:00 12:00	Plenary Session 2: CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? (Obiageli Eunice Nnodu, Nigeria) PL2 AgnesFogo Chairperson United States GuillermoRosa Diez Chairperson guillermo.rosadiez@hospitalitaliano.org.arArgentinaHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of Nephrology My Story VictoriaGray Speaker vwright_03@yahoo.comUnited States CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? Hugh de Wardener Lecture Obiageli EuniceNnodu Speaker oennodu@gmail.comNigeriaUniversity of Abuja Hall A

Day 2 - Monday April 15, 2024

Time	Session

09:00 10:30	Insights From Understanding Heterogeneous Trajectories to Kidney Failure LF03 FacundoDaminato Chairperson fmdaminato@hotmail.comArgentina Magdalena Madero Chairperson madero.magdalena@gmail.comMexicoChief of Nephrology, Instituto Nacional de Cardiologia Ignachi Chavez PietroRavani Chairperson pravani@ucalgary.caCanadaUniversity of Calgary Non-neoplastic Lesions in Nephrectomy Samples: Implications for Kidney Function JairMunoz Mendoza Speaker JMMendoza@med.miami.eduUnited StatesUniversity of Miami Understanding the Heterogeneous Trajectory of CKD MorganGrams Speaker morgan.grams@nyulangone.orgUnited StatesNew York University Review of Medical Therapies Proven to Delay CKD Progression DoreenZhu Speaker doreen.zhu@ndph.ox.ac.ukUnited KingdomUniversity of Oxford Impact of Obesity and Novel Treatment Strategies on CKD Progression PeterRossing Speaker Peter.Rossing@regionh.dkDenmarkSteno Diabetes Center Copenhagen Q and A Hall C4	Hypertension - the Cutting Edge: Advances in Science and Management IK03 TaraChang Chairperson United StatesStanford University Veronica Ferraris Chairperson veronica.ferraris@hospitalitaliano.org.arServicio de Nefrología Pediátrica. Hospital Italiano de Buenos Aires. (Argentina) Behind the Numbers: Exploring the Molecular Mechanisms of Hypertension GerardoGamba Speaker gamba@biomedicas.unam.mxMexicoUniversidad Nacional Autónoma de México Hypertension - the Cutting Edge: Is It Time for Sex-specific Management of Hypertension? TaliElfassy Speaker t.elfassy@med.miami.eduUnited States State-of-the-Art Treatment of Hypertension in Pediatrics With CKD RahulChanchlani Speaker chanchlr@mcmaster.caCanadaMcMaster Children's Hospital, Hamilton, Canada State-of-the-Art Treatment of Hypertension in Adults With CKD SusanneNicholas Speaker sunicholas@mednet.ucla.eduUnited StatesDavid Geffen School of Medicine at UCLA Q and A Hall D
16:30 17:30	Personalized Kidney Replacement Treatment: Adapting Guidelines to Real-world Scenarios LF06 Annie-ClaireNadeau-Fredette Chairperson CanadaUniversité de Montréal Gabriel NicolasContreras Martin Chairperson gcontrer@med.miami.eduUnited StatesUniversity of Miami Miller School of Medicine Maria ElenaBiain Chairperson mariaelenabiain@yahoo.com.arMédica Nefróloga The Who, What, Where, When and Why of Incremental Hemodialysis ConnieRhee Speaker crhee@mednet.ucla.eduUnited StatesUCLA The Changing Landscape of Home Hemodialysis: Is There a Right Patient for Home Hemodialysis? KarthikTennankore Speaker ktennankore@gmail.comCanadaNova Scotia Health/Dalhousie University Patient-, Center- and Country-related Risk Factors for Peritoneal Dialysis Attrition: Can We Prevent It? RosileneM Elias Speaker rosilenemotta@hotmail.comBrazilUniversidade de Sao Paulo Q and A Hall C4

Day 3 - Tuesday April 16, 2024

Time	Session

11:00 12:15	Plenary Session 4: Insights into SGLT2 Inhibitors: A Story of Discovery (Ele Ferrannini, Italy) PL4 AlessiaFornoni Chairperson United StatesUniversity of Miami LizLightstone Chairperson United KingdomImperial College London MasaomiNangaku Chairperson JapanThe University of Tokyo Acceptance Speech: Bywaters Award MotokoYanagita Speaker JapanKyoto University Insights into SGLT2 Inhibitors: A Story of Discovery. Donald Seldin Lecture EleFerrannini Speaker eleferrannini@gmail.comItalyUniversity of Pisa ELP2 Graduation MasaomiNangaku Speaker JapanThe University of Tokyo Hall A

Time

Session

11:00

12:15

Plenary Session 4: Insights into SGLT2 Inhibitors: A Story of Discovery (Ele Ferrannini, Italy)

PL4

AlessiaFornoni Chairperson United StatesUniversity of Miami

LizLightstone Chairperson United KingdomImperial College London

MasaomiNangaku Chairperson JapanThe University of Tokyo

Acceptance Speech: Bywaters Award

MotokoYanagita Speaker JapanKyoto University
Insights into SGLT2 Inhibitors: A Story of Discovery. Donald Seldin Lecture

EleFerrannini Speaker eleferrannini@gmail.comItalyUniversity of Pisa
ELP2 Graduation

MasaomiNangaku Speaker JapanThe University of Tokyo

Hall A